YanPengMDPhD

Pathology • Dallas, TX

Cytopathology, Anatomic Pathology, Clinical Pathology, Surgical Pathology

Professor of Pathology

Join to view full profile

Dr. Peng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Peng's full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-590-2171

Fax+1 214-590-1411
Is this information wrong?

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Cytopathology, 2004 - 2005
UPMC Medical EducationFellowship, Gynecologic Pathology, 2003 - 2004
UPMC Medical EducationResidency, Pathology-Anatomic and Clinical, 1999 - 2003
Mayo Clinic College of MedicinePost-Doctoral Fellowship, Department of Physiology and Medicine , 1993 - 1995
Beijing Medical UniversityPhD, Renal Physiology, 1986 - 1991
Beijing Medical UniversityClass of 1986

Certifications & Licensure

TX State Medical License 2005 - 2025
PA State Medical License 2000 - 2004
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Cytopathology

Publications & Presentations

PubMed

3 citations
Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma.
Qiqi Ye, Hui Chen, Cody Han, Yan Peng, Xiao Huang, Hongxia Sun, Yun Wu, Constance T Albarracin, Lavinia P Middleton, Aysegul A Sahin, Lei Huo, Qingqing Ding> ;Journal of Clinical Pathology. 2023 Aug 16
14 citations
Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer.
Huina Zhang, Yan Peng> ;Cancers. 2022 Dec 25
56 citations
The Changing Paradigm for the Treatment of HER2-Positive Breast Cancer.
Aena Patel, Nisha Unni, Yan Peng> ;Cancers. 2020 Jul 28
18 citations
Up-regulation of PARP1 expression significantly correlated with poor survival in mucosal melanomas
Piotr Donizy, Cheng Lin Wu, Jason Mull, Masakazu Fujimoto, Agata Chłopik, Yan Peng, Sara C. Shalin, M. Angelica Selim, Susana Puig, María Teresa Fernández-Figueras, Ch...> ;Cells. 2020 May 5
5 citations
Collision Tumor of Endometrial Large Cell Neuroendocrine Carcinoma and Low-Grade Endometrial Stromal Sarcoma: A Case Report and Review of the Literature.
Glorimar Rivera, Shuang Niu, Hao Chen, Yan Peng> ;International Journal of Surgical Pathology. 2020 Jan 28
53 citations
EndothelinB receptor activates NHE-3 by a Ca2+ -dependent pathway in OKP cells
Yan Peng, A. Cano, Masashi Yanagisawa, Robert J. Alpern> ;The Journal of Clinical Investigation. 1996 Mar 15
53 citations
Role of tyrosine kinase pathways in ETB receptor activation of NHE3.
Tzong-Shinn Chu, Yan Peng, A. Cano, Masashi Yanagisawa, Robert J. Alpern> ;The American Journal of Physiology. 1996 Sep 1
34 citations
Glucocorticoids enhance acid activation of the Na+/H+ exchanger 3 (NHE3)
Patrice M. Ambühl, Yan Peng, Patricia A. Preisig, Orson W. Moe, Robert J. Alpern> ;The Journal of Clinical Investigation. 1999 Feb 1
ETB receptor activation leads to activation and phosphorylation of NHE3.
Peng Y, Moe OW, Chu T, Preisig PA, Yanagisawa M, Alpern RJ> ;The American journal of physiology.
64 citations
Acid incubation causes exocytic insertion of NHE3 in OKP cells
Xiaojing Yang, Yan Peng, Orson W. Moe, Patricia A. Preisig, Robert J. Alpern> ;American Journal of Physiology. Cell Physiology. 2000 Aug 1
ET(B) receptor activation causes exocytic insertion of NHE3 in OKP cells.
Peng Y, Amemiya M, Yang X, Fan L, Moe OW, Yin H, Preisig PA, Yanagisawa M, Alpern RJ> ;American journal of physiology. Renal physiology.
11 citations
Lztfl1/BBS17 controls energy homeostasis by regulating the leptin signaling in the hypothalamic neurons.
Qun Wei, Yi Feng Gu, Qing Jun Zhang, Helena Yu, Yan Peng, Kevin W. Williams, Ruitao Wang, Kajiang Yu, Tiemin Liu, Zhi Ping Liu> ;Journal of Molecular Cell Biology. 2018 Oct 1
27 citations
CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy
Bray Denard, Sharon Jiang, Yan Peng, Jin Ye> ;BMC Cancer. 2018 Aug 13
Taxol Induces Brk-dependent Pro-survival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.
Regan Anderson, T. M.,Ma, S.,Perez Kerkvliet, C.,Peng, Y.,Helle, T. M.,Krutilina, R. I.,Raj, G. V.,Cidlowski, J. A.,Ostrander, J. H.,Schwertfeger, K. L.,Seagroves, T. ...> ;Mol. Cancer Res.. 2018 Jul 12
Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker.
O'Conor CJ, Chen T, González I, Cao D, Peng Y> ;Biomarkers in medicine. 2018-06-15
100 citations
ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis
Yan Chen, Bo Zhang, Lei Bao, Lai Jin, Mingming Yang, Yan Peng, Ashwani Kumar, Jennifer E. Wang, Chenliang Wang, Xuan Zou, Chao Xing, Yingfei Wang, Weibo Luo> ;The Journal of Clinical Investigation. 2018 May 1
14 citations
Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas
Agata Chłopik, M. Angelica Selim, Yan Peng, Cheng Lin Wu, Gemma Tell-Marti, Kristen M. Paral, Sara C. Shalin, Stefan Kraft, Chao Kai Hsu, Christopher R. Shea, Susana P...> ;Human Pathology. 2018 Mar 1
12 citations
KIT mutations and CD117 overexpression are markers of better progression‐free survival in vulvar melanomas
Dora Dias-Santagata, Maria Angelica Selim, Yuhua Su, Yan Peng, Robin T. Vollmer, Agata Chłopik, Gemma Tell-Marti, Kristen M. Paral, Sara C. Shalin, Christopher R. Shea...> ;The British Journal of Dermatology. 2017 Nov 1
22 citations
Diagnostic Utility of SATB2 in Metastatic Krukenberg Tumors of the Ovary: An Immunohistochemical Study of 70 Cases With Comparison to CDX2, CK7, CK20, Chromogranin, an...
Chen Yang, Li Sun, Lingxin Zhang, Lixin Zhou, Ming Zhao, Yan Peng, Dongfeng Niu, Zhongwu Li, Xiaozheng Huang, Qiang Kang, Lin Jia, Jinping Lai, Dengfeng Cao> ;The American Journal of Surgical Pathology. 2018 Feb 1
29 citations
Nuclear receptor NR4A1 is a tumor suppressor down-regulated in triple-negative breast cancer.
Hongmei Wu, Jiong Bi, Yan Peng, Lei Huo, Xiaobin Yu, Zhihui Yang, Yunyun Zhou, Li Qin, Yixiang Xu, Lan Liao, Yang Xie, Orla M. Conneely, Jos Jonkers, Jianming Xu> ;Oncotarget. 2017 Apr 29
11 citations
Update on Immunohistochemical Analysis in Breast Lesions.
Yan Peng, Yasmeen M. Butt, Beiyun Chen, Xinmin Zhang, Ping Tang> ;Archives of Pathology & Laboratory Medicine. 2017 Jun 5
Mice with Sclerostin Gene Deletion Are Resistant to the Severe Sublesional Bone Loss Induced by Spinal Cord Injury
Y Qin, J Pan, Y Wu, X Li, W Zhao, J Li, C P Cardozo, Y Peng> ;Osteoporosis international.
15 citations
Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: Comparison with GATA3 expression and PELP1's potential rol...
Daniel N. Dang, Ganesh V. Raj, Venetia R. Sarode, Kyle Molberg, Ratna K. Vadlamudi, Yan Peng> ;Human Pathology. 2015 Dec 1
12 citations
Quantification of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Using the Ventana Image Analysis System: Correlation With Gene Amplification by Fluores...
Jake Dennis, Rezvaneh Parsa, Donnie Chau, Prasad Koduru, Yan Peng, Yisheng V. Fang, Venetia R. Sarode> ;The American Journal of Surgical Pathology. 2015 Apr 28
18 citations
Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells
Samaya Rajeshwari Krishnan, Binoj C. Nair, Gangadhara R. Sareddy, Sudipa Saha Roy, Mohan Natarajan, Takayoshi Suzuki, Yan Peng, Ganesh V. Raj, Ratna K. Vadlamudi> ;Breast Cancer Research and Treatment. 2015 Mar 19
Join now to see all

Professional Memberships

United States and Canadian Academy of Pathology - USCAP
Member

Hospital Affiliations

William P. Clements, Jr. University HospitalDallas, Texas
University of Texas Southwestern Medical CenterDallas, Texas
Parkland HealthDallas, Texas